1-[6-Amino-8-(3-fluoro-phenyl)-9-methyl-9H-purin-2-yl]-3-ethyl-pent-1-yn-3-ol

ID: ALA51192

PubChem CID: 10665761

Max Phase: Preclinical

Molecular Formula: C19H20FN5O

Molecular Weight: 353.40

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC(O)(C#Cc1nc(N)c2nc(-c3cccc(F)c3)n(C)c2n1)CC

Standard InChI:  InChI=1S/C19H20FN5O/c1-4-19(26,5-2)10-9-14-22-16(21)15-18(23-14)25(3)17(24-15)12-7-6-8-13(20)11-12/h6-8,11,26H,4-5H2,1-3H3,(H2,21,22,23)

Standard InChI Key:  NPLLJKJORHIIMF-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
    6.3167   -6.5625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8917   -6.7417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3167   -5.9625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2292   -6.2625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8917   -5.7750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8042   -6.8625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8042   -5.6625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2792   -5.9667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2792   -6.5542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7542   -6.8500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2231   -7.1492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8292   -6.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7047   -7.4524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1542   -5.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8167   -5.0625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0792   -7.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7542   -5.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0917   -5.3125    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.4056   -6.9296    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1042   -6.8375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7042   -6.8625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1863   -7.7596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0038   -7.9792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0292   -6.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1869   -8.3597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6039   -7.9786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  2  1  0
  5  3  1  0
  6  1  2  0
  7  3  2  0
  8  9  2  0
  9  6  1  0
 10  9  1  0
 11 10  3  0
 12  4  1  0
 13 11  1  0
 14 12  1  0
 15  7  1  0
 16  2  1  0
 17 14  2  0
 18 17  1  0
 19 13  1  0
 20 12  2  0
 21 20  1  0
 22 13  1  0
 23 13  1  0
 24 21  2  0
 25 22  1  0
 26 23  1  0
  5  4  2  0
  7  8  1  0
 24 17  1  0
M  END

Associated Targets(Human)

ADORA2B Tclin Adenosine A2b receptor (7672 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adora2b Adenosine A2b receptor (205 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 353.40Molecular Weight (Monoisotopic): 353.1652AlogP: 2.65#Rotatable Bonds: 3
Polar Surface Area: 89.85Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.99CX Basic pKa: 3.59CX LogP: 3.88CX LogD: 3.88
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.71Np Likeness Score: -0.76

References

1. Harada H, Asano O, Hoshino Y, Yoshikawa S, Matsukura M, Kabasawa Y, Niijima J, Kotake Y, Watanabe N, Kawata T, Inoue T, Horizoe T, Yasuda N, Minami H, Nagata K, Murakami M, Nagaoka J, Kobayashi S, Tanaka I, Abe S..  (2001)  2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A(2B) receptor.,  44  (2): [PMID:11170626] [10.1021/jm990499b]

Source